ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 265 filers reported holding ROYALTY PHARMA PLC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $414,770 | -28.4% | 15,283 | -18.9% | 0.00% | – |
| Q2 2023 | $579,080 | -13.3% | 18,838 | +1.6% | 0.00% | -100.0% |
| Q1 2023 | $668,068 | +123.7% | 18,542 | +145.3% | 0.00% | – |
| Q4 2022 | $298,692 | -25.0% | 7,558 | -23.6% | 0.00% | – |
| Q3 2022 | $398,000 | +3.6% | 9,895 | +8.4% | 0.00% | – |
| Q2 2022 | $384,000 | +42.2% | 9,132 | +31.8% | 0.00% | – |
| Q1 2022 | $270,000 | -12.3% | 6,931 | -10.2% | 0.00% | – |
| Q4 2021 | $308,000 | +8.1% | 7,720 | +35.6% | 0.00% | – |
| Q4 2020 | $285,000 | -65.7% | 5,694 | -71.2% | 0.00% | -100.0% |
| Q3 2020 | $831,000 | +92.8% | 19,750 | +122.3% | 0.00% | 0.0% |
| Q2 2020 | $431,000 | – | 8,883 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |